Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Covaxin granted restricted EUA
Bharat Biotech's indigenously developed Covaxin is out of the "clinical trial mode" and it has now been granted the restricted…
J&J gets positive CHMP opinion for single-shot COVID-19 vaccine candidate
If granted conditional marketing authorisation by the EC, the J&J single-shot COVID-19 vaccine will be available in the EU
Parikh family sells stake in ZCL Chemicals to Advent in Rs 2,000 crore deal
The transaction marks one of the largest exits in the API space
Low patient accrual rates cause termination of over 25 per cent rare disease trials: GlobalData
Difficulties with patient recruitment for rare disease clinical trials could be mitigated by the use of virtual trials
Lilly’s bamlanivimab plus etesevimab cut death, hospitalisations for early COVID-19 in Phase…
Results support use of bamlanivimab 700 mg and etesevimab 1400 mg, the dose authorised in the US and several other countries
Pfizer interested in producing vaccine in India if speedy clearance, export freedom assured: Reports
Pfizer withdrew an application last month seeking EUA for its product in India after the DCGI declined its request to skip a small…
AstraZeneca Pharma India gets DCGI approval for Osimertinib tablets
It is now approved as monotherapy for adjuvant treatment after complete tumour resection in patients with NSCLC
ICRI, SBSU Dehradun collaborate to advance clinical research and healthcare programmes
Sign MOU to provide specialised courses and programmes for undergraduate and postgraduate students to bridge the gap between the…
CEPI plans 100-day target for new vaccines against emerging disease epidemics
Compressing vaccine development timelines to 100 days would make them around a third as long as it took the world to develop the…
Lupin launches Nitazoxanide Tablets
They are indicated in the treatment of diarrhoea caused by Giardia lamblia or Cryptosporidium parvum